DRUG · COUNSELLING NOTES
Enfortumab Vedotin
PADCEV
Updated
New prescription
indication: _____. IV in clinic; report rash/blisters; warned on allergies; serious/common AEs: SJS/TEN, neuropathy, high blood sugar, hair loss; non-pharm: moisturizer, sun protection.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV in clinic; report rash/blisters; warned on allergies; serious/common AEs: SJS/TEN, neuropathy, high blood sugar, hair loss; non-pharm: moisturizer, sun protection.